O'Brien Greene & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $763K | Sell |
979
-3
| -0.3% | -$2.34K | 0.25% | 63 |
|
|
2025
Q1 | $811K | Sell |
982
-1
| -0.1% | -$826 | 0.27% | 58 |
|
|
2024
Q4 | $759K | Buy |
983
+79
| +9% | +$61K | 0.25% | 65 |
|
|
2024
Q3 | $801K | Sell |
904
-51
| -5% | -$45.2K | 0.25% | 66 |
|
|
2024
Q2 | $865K | Buy |
955
+12
| +1% | +$10.9K | 0.27% | 60 |
|
|
2024
Q1 | $734K | Hold |
943
| – | – | 0.24% | 69 |
|
|
2023
Q4 | $550K | Buy |
943
+35
| +4% | +$20.4K | 0.19% | 78 |
|
|
2023
Q3 | $488K | Sell |
908
-7
| -0.8% | -$3.76K | 0.18% | 81 |
|
|
2023
Q2 | $429K | Sell |
915
-25
| -3% | -$11.7K | 0.15% | 87 |
|
|
2023
Q1 | $323K | Hold |
940
| – | – | 0.12% | 105 |
|
|
2022
Q4 | $344K | Sell |
940
-1,925
| -67% | -$704K | 0.13% | 103 |
|
|
2022
Q3 | $927K | Buy |
2,865
+1,910
| +200% | +$618K | 0.12% | 106 |
|
|
2022
Q2 | $310K | Hold |
955
| – | – | 0.12% | 112 |
|
|
2022
Q1 | $273K | Sell |
955
-1
| -0.1% | -$286 | 0.09% | 120 |
|
|
2021
Q4 | $264K | Buy |
956
+56
| +6% | +$15.5K | 0.09% | 123 |
|
|
2021
Q3 | $208K | Hold |
900
| – | – | 0.08% | 128 |
|
|
2021
Q2 | $207K | Buy |
+900
| New | +$207K | 0.07% | 131 |
|